Frankfurt - Delayed Quote • EUR BioVaxys Technology Corp. (5LB.F) Follow Add holdings 0.0320 +0.0190 +(146.15%) As of May 13 at 2:06:46 PM GMT+2. Market Open. Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 5LB.F 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: 5LB.F View More All News Press Releases SEC Filings BioVaxys and Sona partner to develop cancer therapeutics BioVaxys and Sona Nanotech Enter Research Collaboration BioVaxys and SpayVac-for-Wildlife Expand License Agreement Into Commercial Aquaculture BioVaxys Technology Corp. Announces Revocation of Management Cease Trade Order and Closing of Debt Settlement Transaction BioVaxys Technology Corp. Granted Management Cease Trade Order BioVaxys Announces Debt Settlement Agreement, Extension of Private Placement Closing Date and Closing of The Fourth and Final Tranche of Private Placement BioVaxys Announces Application for Management Cease Trade Order BIOVAXYS ANNOUNCES EXTENSION OF PRIVATE PLACEMENT CLOSING DATE BioVaxys Developing DPX to be 'Carrier of Choice' for mRNA Vaccines BioVaxys Developing DPX to be the Carrier of Choice for mRNA Vaccines, a market projected to grow to USD$48,000,000,000 by 2030* Presenting on the Emerging Growth Conference 78 Day 2 on January 16 Register Now